Hybrid Cardiac Rehabilitation Program in a Low-Resource Setting: A Randomized Clinical Trial

Pamela Seron1,2, Maria Jose Oliveros1,2, Gabriel Nasri Marzuca-Nassr1

  • 1Facultad de Medicina, Departamento de Ciencias de la Rehabilitación, Universidad de La Frontera, Temuco, Chile.

JAMA Network Open
|January 9, 2024
PubMed

Insights

Hybrid cardiovascular rehabilitation (CR) is noninferior to standard CR for preventing cardiovascular events in lower-resource settings. This hybrid model may improve adherence to supervised exercise, offering a viable alternative for broader implementation.

Area of Science:

  • Cardiology
  • Rehabilitation Medicine
  • Public Health

Background:

  • Traditional cardiovascular rehabilitation (CR) faces implementation challenges in lower-resource settings.
  • Effective CR is crucial for managing cardiovascular events and improving patient outcomes.

Purpose of the Study:

  • To evaluate the noninferiority of a hybrid CR model compared to traditional CR regarding cardiovascular events.
  • To assess secondary outcomes including quality of life, return to work, lifestyle behaviors, and adherence.

Main Methods:

  • A pragmatic, multicenter, randomized clinical trial (HYCARET) involving adults post-cardiovascular event.
  • Participants received either 10 center-based sessions with remote support (hybrid CR) or 18-22 center-based sessions (standard CR).
  • Primary outcome was cardiovascular events or mortality, with follow-up for 1 year.

Main Results:

  • Hybrid CR demonstrated noninferiority to standard CR, with fewer cardiovascular events in the hybrid group (5.38% vs. 9.18%).
  • No significant differences were observed in most secondary outcomes, except for superior adherence to supervised exercise sessions in the hybrid CR group.
  • Per-protocol analyses indicated that noninferiority was maintained across different adherence levels.

Conclusions:

  • Hybrid CR is a noninferior alternative to standard CR in low-resource settings, particularly for preventing recurrent cardiovascular events.
  • The hybrid model shows potential for superior adherence to supervised exercise.
  • Allocation to CR models should consider clinical factors and patient preferences.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...